Abstract:Objective To evaluate the causes of alanine aminotransferase (ALT) level elevation in HBsAg-positive chronic hepatitis B (CHB) patients with low HBV DNA loads. Methods One hundred nineteen HBsAg positive CHB patients with both serum HBV DNA loads < 103 copies/ml and ALT>1.25 upper limits of normal (ULN) lasting for at least 6 months were enrolled in this study. Patients co-infected with hepatitis C virus or HIV or suffering from other liver diseases were not included. HBV DNA loads were assayed by PCR. Serological biochemistry and liver biopsy histopathological changes and clinical character-istics of the patients were analyzed. Results Of the 119 patients 102 were males and 17 were females. The mean age of the patients was (33.9±9.7) years and their body mass index (BMI) was (23.4±3.7) kg/m2.Mean ALT levels were (150.0±166.6) U/L and AST levels were (102.4±193.2) U/L. Liver biopsies showed hepatic steatosis in 26.9 % (32/119) of the cases, chronic hepatitis in 53.8% (64/119), non-specific changes in 12.6% (15/119), and l without any change. However, hepatic steatosis was more frequently seen in patients taking nucleoside analogs (56.7%), χ2= 10.394, P < 0.01. BMI, apolipoprotein B (APO-B), triglyceride,cholesterol and uric acid were all significantly higher in patients with hepatic steatosis than those without (t values were 5.369, 4.276, 3.216, 4.223 and 2.438 respectively, all P < 0.05) while ALT, AST and apolipoprotein A were much lower in those with steatosis than those without (t values were -2.234, -3.877 and -2.956 respectively, all P < 0.05). Obesity, dyslipidemia and hyperuricemia were more frequently seen in patients with steatosis than in patients without it (χ2 value 3.829, 7.659, 13.389, 0.549, all P< 0.05). The severity of inflammation and fibrosis were also more significant in patients with steatosis (χ2 value 20.978, 17.550, all P < 0.05). As compared to those patients without specific changes, serum levels of ALT, AST, GGT in patients with chronic hepatitis were obviously higher, all P < 0.05. In contrast, there were no significant differences in mean age, BMI, male preference, obesity, diabates, dyslipidemia or hyperuricemia, and the levels of triglyceride,cholesterol, and fasting plasma glucose between the two groups. Conclusion Our data indicate that hepatic steatosis might be a factor associated with elevated ALT levels in HBsAg-positivc CHB patients with low HBV DNA loads, especially in patients treated with nucleoside analogs.

Air pollution impede ALT normalization in chronic hepatitis B patients treated with nucleotide/nucleoside analogues

[Alanine Aminotransferase Normalization with Antiviral Therapies in Hepatitis B].

Anti-viral effect in chronic hepatitis B patients with normal or mildly elevated alanine aminotransferase

High Normal Alanine Aminotransferase is an Indicator for Better Response to Antiviral Therapy in Chronic Hepatitis B

Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study

The Efficacy of Antiviral Treatment for Chronic Hepatitis B Patients with Normal ALT Levels: A Systematic Review and Meta-analysis

Systematic Review with Meta‐analysis: Significant Histological Changes among Treatment‐naïve Chronic Hepatitis B Patients with Normal Alanine Aminotransferase Levels by Different Criteria

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues

Histological findings and its influencing factors of HBeAg-negative chronic hepatitis B virus-infected patients with persistently normal alanine aminotransferase levels

Hepatic stetaosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads

Antiviral Therapy for Chronic HBV Infection With Persistently Normal Alanine Aminotransferase: Controversy and Consensus

Histological features of chronic hepatitis B patients with normal alanine aminotransferase according to different criteria

Patients with chronic hepatitis B who have persistently normal alanine aminotransferase or aged < 30 years may exhibit significant histologic damage

Significance of changes in hepatic histology from patients with HBeAg(+)or HBeAg(-)chronic hepatitis B and normal or mildly elevated alanine aminotransferase

An Assessment of Upper Limits of Normal for ALT and the Impact on Evaluating Natural Course of Chronic Hepatitis B Virus Infection in Chinese Children.

Circulating metabolites are associated with persistent elevations of ALT in patients with chronic hepatitis B with complete viral suppression

Clinical Trail of Decoction of Tonifying Qi Activating Blood and Detoxifcation in the Treatment of Chronic Hepatitis B Patients with Alanine Aminotransferase Less than Two-time upper Limits of Normal Level

Significant histological changes and satisfying antiviral efficacy in chronic hepatitis B virus infection patients with normal alanine aminotransferase. Antiviral therapy decision in chronic HBV patients with normal ALT

Significant histopathology in Chinese chronic hepatitis B patients with persistently high-normal alanine aminotransferase.

[Hepatitis B Virus Genotypes and Alanine Aminotransferase Levels in HBeAg Negative Patients with Chronic Hepatitis B and Liver Cirrhosis].